Last updated on March 2019

Descriptive Observational Study ALK-2016-CPHG


Brief description of study

Descriptive Observational Study.

Characteristics Of ALK-positive and ROS1-positive Adults Patients Non-Small Cell Lung Cancer (NSCLC) Treated With Crizotinib Within General Hospitals

Detailed Study Description

Describe the characteristics of patients treated with crizotinib Describe efficacy, safety, observance and QoL.

Clinical Study Identifier: NCT03718117

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Centre Hospitalier General Beziers, Service De Pneumologie
Beziers, France
2.53miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.